RACHEL SCANLAN: Open Payments
NPI 1619150315 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 13 payments from 7 companies in 2025. Trend: 2023 $1,954 · 2024 $1,085 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $151 |
| Novo Nordisk Inc | 1 | $91 |
| Lilly USA, LLC | 1 | $89 |
| Lundbeck LLC | 3 | $46 |
| Vertical Pharmaceuticals, LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Corium, LLC | 2 | $13 |
Products named: LYBALVI, Ozempic, ZEPBOUND, REXULTI, ARISTADA, Relexxii, TRINTELLIX, Azstarys.
Industry payments across FL — which companies pay providers there.
